Health · Medical Research · 10 hrs ago
Breast cancer survivor meets researcher whose work helped her treatment
Sylvie Dax, 46, travelled from Gap to Paris to meet Capucine Grandjean, a researcher at the Institut Pasteur.
Dax had an aggressive breast cancer and is now in remission.
During two years of treatment, she had 28 chemotherapy sessions, two operations and breast reconstruction.
She credits immunotherapy with helping her recover; Grandjean specialises in this type of treatment, which uses the immune system to fight cancer.
Immunotherapy has been used since 2011 and helps treat thousands of people with cancer in France each year, sometimes extending lives or leading to recovery.
The meeting showed how research can affect patients’ lives, while giving researchers a rare chance to meet someone in remission.
Donations provide more than a third of the Institut Pasteur’s budget and help support its research.
Sylvie Dax, a 46-year-old breast cancer survivor, met researcher Capucine Grandjean, whose work may have helped her treatment.
Dax said she was grateful to Grandjean and credited her with helping her be alive.
Dax spent two years battling an aggressive breast cancer and is now in remission.
After 28 chemotherapy treatments and two operations, she received immunotherapy, Grandjean’s specialty.
The meeting took place at the Pasteur Institute in Paris and was presented in connection with the Pasteurdon’s 20th anniversary.
- Who
- Sylvie Dax, a 46-year-old breast cancer survivor, met Capucine Grandjean, a researcher at the Pasteur Institute.
- What
- They met after Dax’s treatment for aggressive breast cancer, which included immunotherapy.
- When
- 11 October 2026.
- Where
- The Pasteur Institute in Paris.
- Why
- Dax came to thank Grandjean, whose work may have helped her treatment.
This story does not have two clearly opposing sides.
Thank you so much from the bottom of my heart, because it’s thanks to you that I’m here today.
These patients are now sometimes completely cured or they have really gained in life expectancy. Immunotherapy is revolutionary.
We have the right to live our lives as we want, all the more so after illness.
Sylvie Dax battled an aggressive breast cancer.
Dax received 28 chemotherapy treatments, underwent two operations and had breast reconstruction.
Dax met researcher Capucine Grandjean at the Pasteur Institute in Paris.
- Patient
- Sylvie Dax, 46
- Researcher
- Capucine Grandjean, Pasteur Institute
- Treatment
- Immunotherapy
- Chemotherapy
- 28 treatments
- Treatment period
- Two years
Sources
Related news
Pope Leo XIV to have lung nodule removed in surgery this week
Pope Leo to have surgery to remove an early-detected lung nodule
Pope Leo XIV to have surgery to remove early-stage lung nodule
Electroacupuncture reduced post-shingles pain in a clinical trial
AI model uses past mammograms to estimate breast cancer risk
ADHD and Later Cognitive Diagnoses: Why the Risk Estimate Needs Context
Higher Pre-Surgery A1c Linked to Macular Edema Risk After Cataract Surgery
PRIMA retinal implant showed control of geographic atrophy for up to 3 years
Pedro Bial says he has emphysema linked to past smoking
Bonn researchers reset age markers in human cells in the lab
Google’s AMIE chatbot may help doctors prepare for patient visits
